Results 111 to 120 of about 4,073,186 (254)

Cardiovascular-Kidney-Metabolic Syndrome: Review of a Pathogenesis through the Prism of Insulin Resistance

open access: yesИнновационная медицина Кубани
This article presents a review of the pathogenesis of cardiovascular-kidney-metabolic syndrome – a multifactorial condition in which cardiovascular, renal, and metabolic disorders mutually aggravate each other.
A. A. Avagimyan   +9 more
doaj   +1 more source

Drug Repurposing in Pre‐Eclampsia: Maternal Pharmacokinetic and Pharmacodynamic Considerations for Clinical Trial Design

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Pre‐eclampsia is a hypertensive disorder of pregnancy affecting 3–8% of pregnancies worldwide, with no disease‐modifying therapy currently available. Drug repurposing offers a promising strategy, yet no candidate has been validated to date. Pregnancy‐associated physiological changes alter drug pharmacokinetics (PK), and pre‐eclampsia itself may further
Cassius M. Phogole   +4 more
wiley   +1 more source

Incorporation of Metabolic Dysfunction‐Associated Steatotic Liver Disease in the Health Stage of Cardiovascular‐Kidney‐Metabolic Syndrome Improves Predictive Ability for Coronary Artery Disease in a Japanese General Population

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Cardiovascular‐kidney‐metabolic (CKM) syndrome is a recently proposed condition encompassing metabolic dysfunction, chronic kidney disease, and cardiovascular diseases including coronary artery disease (CAD).
Wataru Kawaharata   +12 more
doaj   +1 more source

Maternal Polyphenols and Offspring Cardiovascular–Kidney–Metabolic Health

open access: yes
Background: The convergence of cardiovascular, kidney, and metabolic disorders at the pathophysiological level has led to the recognition of cardiovascular–kidney–metabolic (CKM) syndrome, which represents a significant global health ...
Chien-Ning Hsu, You-Lin Tain
core   +1 more source

Does diagnosis of the metabolic syndrome detect further men at risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score?

open access: yes, 2007
It is not known whether the metabolic syndrome detects further individuals at high risk of death from cardiovascular disease (CVD), beyond those identified by a conventional cardiovascular risk score.A prospective study.A total of 2790 men without ...
Stehouwer, C.D.A.   +2 more
core   +1 more source

Membrane lipid metabolism as a regulatory frontier in neural crest biology: Roles for sphingolipids, cholesterol, and lipid rafts

open access: yesDevelopmental Dynamics, EarlyView.
Abstract Neural crest cells are multipotent, migratory stem‐like cells essential for vertebrate development that contribute broadly to many tissues including the craniofacial skeleton, peripheral nervous system, and pigment‐producing cells. Their development progresses through phases of induction, specification, delamination, migration, and ...
Allison E. Mancini   +2 more
wiley   +1 more source

Effects of maternal high fat diet and pharmacological intervention on the developmental origins of metabolic & cardiovascular disease

open access: yes, 2011
A high fat (HF) diet leads to hypercholesterolemia and predisposes the individual to developing cardiovascular disease (CVD). We hypothesised that mother‘s HF diet before and during pregnancy and lactation can also influence predisposition to CVD in ...
Elahi, Maqsood M.
core   +1 more source

Development, structure, and implementation of cardiometabolic clinics in the United States, with a focus on comprehensive patient care

open access: yesAmerican Journal of Preventive Cardiology
Metabolic syndrome and associated cardiometabolic risk factors affect over one‑third of US adults, increasing the risk for atherosclerotic cardiovascular disease, type 2 diabetes, and chronic kidney disease.
Jodeanna Sweeney   +3 more
doaj   +1 more source

Role of selenium in the pathophysiology of cardiorenal anaemia syndrome

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 770-780, April 2025.
Abstract Chronic kidney disease (CKD) and cardiovascular disease (CVD) have multiple bidirectional mechanisms, and anaemia is one of the critical factors that are associated with the progression of the two disorders [referred to as cardiorenal anaemia syndrome (CRAS)].
Shigeyuki Arai   +2 more
wiley   +1 more source

CARDIAL-MS (CArdio-Renal-DIAbetes-Liver-Metabolic Syndrome): a new proposition for an integrated multisystem metabolic disease

open access: yesDiabetology & Metabolic Syndrome
Background Metabolic Syndrome—a constellation of insulin resistance, cardiovascular risk factors as hyperglycemia, hypertension, and dyslipidemia, and systemic metabolic dysfunction—may be driven by dysregulation of adipose tissue, which manifests as ...
Amélio F. Godoy-Matos   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy